Compassion Center Urges DEA to Reschedule Cannabis to Schedule III During December 2, 2024, Hearing

1 year ago

Compassion Center urges the DEA to reschedule cannabis to Schedule III of the Controlled Substances Act during the December 2,…

Sunknowledge Services Inc. Ensures Unparalleled Accuracy in its Medical Coding Services

1 year ago

Sunknowledge Services Inc. Sets the Gold Standard in Medical Coding Excellence, Enhancing Revenue Cycle Management for Healthcare Providers NEW YORK…

Sunshine Biopharma Announces Publication of Significant Coronavirus Research Results in the Journal of Medicinal Chemistry

1 year ago

Current Test Positivity Rate for Coronavirus Infection in the U.S. is 18%Development of a novel antiviral compound, XR8-23 (Compound 10),…

Revelstoke Capital Partners Announces Significant Growth Investment in MediQuant

1 year ago

DENVER, CO and INDEPENDENCE, OH / ACCESSWIRE / September 4, 2024 / Revelstoke Capital Partners ("Revelstoke"), a healthcare-focused private equity…

CBD Life Sciences, Inc. (CBDL) Unveils Mellow Mornings: A Revolutionary Nano CBD Coffee Creamer Set to Boost Revenue Amid Growing National Demand

1 year ago

SCOTTSDALE, AZ / ACCESSWIRE / September 4, 2024 / CBD Life Sciences, Inc. (OTC PINK:CBDL), a leader in the CBD…

Beta Bionics Announces Partnership With Abbott to Integrate the iLet Bionic Pancreas With the FreeStyle Libre 3 Plus iCGM

1 year ago

IRVINE, CA / ACCESSWIRE / September 4, 2024 / Beta Bionics, Inc., a pioneering leader in the development of advanced…

Telomir Pharmaceuticals Appoints Dr. Itzchak Angel, Former Head of Pharmacology at Synthelabo (Now Sanofi-Aventis), to Lead IND and INAD Applications for Human and Veterinary Indications

1 year ago

MIAMI, FL / ACCESSWIRE / September 4, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a pre-clinical-stage company…

As Research into Pain Accelerates, a Newly Recognized Type of Pain Comes to the Forefront – Tonix Targets it with FDA-Fast Track-Designated TNX-102 SL

1 year ago

CHATHAM, NJ / ACCESSWIRE / September 4, 2024 / This post was written and published as a collaboration between the…

Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

1 year ago

ORLANDO, FL / ACCESSWIRE / September 4, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) has reported its financial results for the second…